Plenary Speakers

Plenary Speakers

Professor Jon Cooper

Professor Jon Cooper holds The Wolfson Chair in Biomedical Engineering and Emeritus Vice Principal at the University of Glasgow. He is an EPSRC Leadership Research Fellow whose major research interests are in medical diagnostics and imaging, with a track record of spin-out and translation of devices into industry and practice. He has published over 260 papers with an H index of 50, including those in ACS Nano, Nature Communications, Advanced Materials, PRL and PNAS. In one example of his current work, rapid, zero-cost multiplexed “origami paper” diagnostics are being trialled in rural East Africa as species-specific DNA sensors to identify the cause of infectious disease and inform treatment amongst under-served rural communities. Further examples of translation of his research include bathroom diagnostics, sold as a bowel cancer test on the high street (e.g. Boots the Chemist), now based in Binhai, Tianjin, China.

He was elected as a Fellow of the Royal Academy of Engineering (UK’s National Academy of Engineering) as well as a Fellow of the Royal Society of Edinburgh (Scotland’s National Academy of Arts, Humanities and Sciences).

Scientia Professor J. Justin Gooding, FAA, FTSE, FISE, FRSN, FRACI, FRSC

Scientia Professor Justin Gooding is currently an ARC Australian Laureate Fellow, the co-director of the Australian Centre for NanoMedicine and the co-director of the New South Wales Smart Sensing Network. He is a Fellow of the Australian Academy of Science and the Australian Academy of Technology and Engineering. He is the inaugural editor-in-chief of the journal ACS Sensors.

He has published over 400 research papers including Nature Nanotechnology, Nature Biotechnology, Nature Immunology, Nature Communications and Science Advances. He has also authored 14 patents and one text book. His papers have been cited more than 20000 times and his H-index (Scopus) is 70. He has won numerous awards including Eureka Prizes in Scientific Research and Mentoring of Young Researchers, the Faraday Medal of the Royal Society of Chemistry,  the Elsevier Biosensors and Bioelectronics Award and the Katsumi Niki Prize in Bioelectrochemistry from the ISE. He has been part of the commercialization teams for a glucose biosensor that is sold worldwide and and an Australian based 3D bioprinting company. He leads a research team of over 40 researchers interested in surface modification and nanotechnology for biosensors, biomaterials, electron transfer and medical applications.

Dr Anand Subramony

Anand Subramony is Vice President of External innovation and Novel Technologies at AstraZeneca. In this role, Anand leads various cross functional teams and initiatives in the areas of nanomedicine, targeted therapy, new modalities, and digital technologies including sensors/diagnostics. His group is also responsible for the next generation FutureLab®, lab automation, and evaluating novel technologies.

Before his current role, Anand headed the drug delivery and device development at Medimmune. Prior to that, he was Principal Fellow and Head of the Novel Delivery Technologies & Therapeutics at the Novartis Institutes for BioMedical Research (NIBR, Cambridge, MA) where he established and managed a high performing cross functional team. In other roles, Dr. Subramony led the Materials Science function of the Biomedical Engineering group at Alza /J&J (Mountain View, CA), and was Director of Materials Science & Drug delivery at Dr. Reddy’s Laboratories (Bridgewater, NJ)

With his broad experience in pharma biotech, Dr. Subramony brings innovation and scientific rigor coupled with execution excellence and sense of urgency towards drug development to create patient centric products. Dr. Subramony holds an MS in Materials Sc. Engineering from IIT Bombay and PhD from Purdue University and was a research scientist at the University of Washington, Seattle before taking up industrial positions. He has several refereed publications and patents in the areas of drug delivery, nanomedicine, and devices.

Professor Tom Wu

Professor Tom Wu received his B.S. degree from Zhejiang University in 1995 and Ph.D. degree from the University of Maryland, College Park in 2002. Before joining University of New South Wales (UNSW) in Sydney as a full professor, he worked as postdoc in Argonne National Laboratory in Chicago, assistant professor in Nanyang Technological University (NTU) Singapore, and associate professor in King Abdullah University of Science and Technology (KAUST). Dr. Wu has authored 260 peer-reviewed papers in the areas of oxide thin films, nanomaterials, and hybrid perovskites, with a focus on their electronic, magnetic and optical functionalities. His works have been cited more than 15,000 times with a H index of 71 (Google Scholar). He is among the 2019 Clarivate Analytics List of Highly Cited Researchers. Dr. Wu also serves as an Associate Editor for ACS Applied Materials & Interfaces.

Professor Wenlong Cheng

Prof. Wenlong Cheng is a professor and director of research in the Department of Chemical Engineering at Monash University, Australia. He is also an Ambassador Tech Fellow in Melbourne Centre for Nanofabrication. He earned his PhD from Chinese Academy of Sciences in 2005 and his BS from Jilin University, China in 1999. He held positions in the Max Planck Institute of Microstructure Physics and the Department of Biological and Environmental Engineering of Cornell University before joining the Monash University in 2010. His research interest lies at the Nano-Bio Interface, particularly self-assembly of 2D plasmonic nanomaterials, DNA nanotechnology, electronic skins and stretchable energy devices. He has published >160 papers including 3 in Nature Nanotech, 1 in Nature Mater, 1 in Nature Comm and 1 in Nature Protocol. He is currently the Scientific Editor for Nanoscale Horizon, the editor for the Elsevier journal – Inorganic Chemistry Communications, and the editorial board members for a few journals including Cell press journal – iScience.

Professor Benjamin Eggleton

Professor Benjamin Eggleton is Director of the University of Sydney Nano Institute (Sydney Nano) and co-Director of the NSW Smart Sensing Network (NSSN). He has been an ARC Laureate Fellow and was founding director of the ARC Centre of Excellence for Ultrahigh Bandwidth Devices for Optical Systems (CUDOS). His ground-breaking research into nanoscale optical waveguides underpins novel applications in telecommunications, quantum technologies and sensing. Professor Eggleton completed his undergraduate and PhD studies at the University of Sydney. He held several roles in industry, including at prestigious Bell Laboratories in the USA, where he was director of photonics devices research, before joining the University of Sydney again in 2003 as professor of physics. Since then, he has received more than $54 million in research grants while at the University. His current research supported by ARC, NSW Government, DST, RAAF and industry partners, emphasizes advanced sensor technologies to enhance satellite communications, radar systems and surveillance capabilities for defence and environmental monitoring. Professor Eggleton has an h-index of 93 (Google scholar) and is the author or co-author of more than 500 journal publications. He has won several prizes, including NSW Scientist of the Year for Physics and Astronomy, the Eureka Prize for Leadership in Science, the Pawsey Medal, the Walter Boas Medal, and a Vice-Chancellor’s Award for Excellence for Outstanding Research. He is a fellow of both the Australian Academy of Science and the Australian Academy of Technological Sciences and Engineering. Eggleton is Editor-in-Chief of APL Photonics.